600568 ST中珠医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-2.616-6.746-29.511-13.097-24.995
总资产报酬率 ROA (%)-2.160-5.577-24.136-10.218-19.564
投入资产回报率 ROIC (%)-2.511-6.479-28.162-11.963-22.363

边际利润分析
销售毛利率 (%)9.17217.92612.76425.22525.191
营业利润率 (%)-17.805-21.511-120.568-52.841-153.849
息税前利润/营业总收入 (%)-18.014-21.455-121.203-55.768-160.161
净利润/营业总收入 (%)-17.933-19.563-119.906-52.996-156.488

收益指标分析
经营活动净收益/利润总额(%)100.81752.19623.12830.46822.939
价值变动净收益/利润总额(%)-1.433-1.37127.3501.6570.715
营业外收支净额/利润总额(%)0.626-2.249-0.2120.2882.859

偿债能力分析
流动比率 (X)3.1703.5163.6894.5223.970
速动比率 (X)2.7232.9132.7753.0592.608
资产负债率 (%)19.04917.40217.81914.18920.899
带息债务/全部投入资本 (%)3.4401.6272.3142.3212.204
股东权益/带息债务 (%)2,765.2525,950.8674,118.9764,115.1333,991.528
股东权益/负债合计 (%)431.879476.190462.933572.895360.577
利息保障倍数 (X)186.23651.345136.27120.09989.791

营运能力分析
应收账款周转天数 (天)58.51452.38761.14252.36361.072
存货周转天数 (天)131.868188.794336.762443.498605.314